title: [Pathogenetic therapy in pulmonary tuberculosis].
abstract: Clinico-biochemical comparisons with an account of the peculiar characteristics of the tuberculosis process showed that it was advisable to use antioxidants as antifibrotic pathogenetic agents. The most pronounced effect was observed when combinations of two antioxidants or one antioxidant with lidase were applied.
authors.forename: E V
authors.initials: EV
authors.lastname: Starostenko
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D015227:Lipid Peroxidation; D011239:Prednisolone / Q000627:therapeutic use; D013885:Thiosulfates / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D014810:Vitamin E / Q000627:therapeutic use
chemical_list: D000975:Antioxidants; D000995:Antitubercular Agents; D005938:Glucocorticoids; D013885:Thiosulfates; D014810:Vitamin E; D011239:Prednisolone; C017717:sodium thiosulfate
vernacular_title: Patogeneticheskaia terapiia pri tuberkuleze legkikh.